Document is current
Any future updates will be listed below
-
Authors
Nishikubo, Kou
Ohgaki, Ryuichi
Liu, Xingming
Okanishi, Hiroki
Xu, Minhui
Endou, Hitoshi
Kanai, Yoshikatsu
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (22J14119, 18K06931, 19H03407)
Japan Agency for Medical Research and Development (JP19cm0106151)
National Institutes of Biomedical Innovation, Health and Nutrition (12–02)
Ministry of Education, Culture, Sports, Science and Technology (H25B7)
J-Pharma Co., Ltd.
- License Information
-
More Information
Article History
Received: 7 April 2023
Accepted: 26 May 2023
First Online: 15 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: Y.K. received a collaborative research grant from J-Pharma Co., Ltd. H.E. founded J-Pharma Co., Ltd. and has led the development of nanvuranlat. Other authors declare no competing interests.
